Abstract: The recurrence rate of benign nevi has been infrequently reported and primarily as a rate of clinical recurrence. The aim of this study was to document the rate of recurrence leading to re-excision of previously biopsied nevi (the clinically significant recurrence rate). Nevi undergoing primary biopsy with a minimum 5 years follow-up were reviewed in a pathology database for recurrence requiring a further excision. A total of 1035 nevi were reviewed including 196 dysplastic nevi. Twenty six percent of nevi had a positive margin, more common in shave and punch than ellipse biopsied lesions. Three cases recurred requiring re-excision resulting in a pathology recurrence rate of 0.3%. These 3 cases showed benign changes and 2 were originally excised with clear margins. The rate of recurrence requiring re-excision is very low at 0.3%. This suggests that few cases of clinical recurrence are re-excised. Re-excision of benign nevi including mild and moderately dysplastic nevi may not be necessary.
*Pathlab Bay of Plenty, Tauranga, New Zealand
†Department of Dermatology, Tauranga Hospital, Tauranga, New Zealand
‡Dermatology institute SKIN, Tauranga, New Zealand
§Diagnostic Medlab, Auckland, New Zealand.
Reprints: Ben Tallon, MBChB, FRACP, Pathlab Bay of Plenty, Elizabeth St, Tauranga, New Zealand (e-mail: email@example.com).
The authors declare no funding or conflict of interest.